Calpain Inhibitors, a Treatment for Alzheimer's Disease

Principal Investigator
Fortunato Battaglia, MD
Research Foundation for Mental Hygiene
New York, NY, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2003 - March 31, 2005
Grant ID
A2003230
Summary
Today’s treatments for Alzheimer’s disease (AD) are simply treat the symptoms without arresting the disease. The next generation of drugs may delay the onset or slow the progression by acting on the cause(s) of the illness. Evidence suggests that the impairment of synaptic communication between neurons may significantly contribute to the symptoms and progressive deterioration associated with AD. Possible candidates as causes of AD are a particular type of proteins called calpains. These proteins have shown the ability to destroy most of the cellular protein pool at abnormally high calcium levels and to regulate the production of beta-amyloid precursor protein, one of the neuropathologic hallmarks of the disease. In so doing, they may be responsible for mediating the early molecular events of the illness. Dr. Battaglia is investigating how a treatment with calpain inhibitors may restore normal communication between synaptic transmission and thereby slow the progression of the disease. Calpain inhibitors have already been used in the therapy of various other diseases. Analyzing the effects of calpain inhibitors in animal models of Alzheimer’s might help to identify a new treatment for AD.
Related Grants
Alzheimer's Disease Research
Understanding the Choroid Plexus in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Monica Santisteban, PhD
Current Organization
Vanderbilt University Medical Center
Understanding the Choroid Plexus in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Monica Santisteban, PhD
Current Organization
Vanderbilt University Medical Center
Alzheimer's Disease Research
Unraveling Vascular Pathways in Dementia through Integrated Computational Fluid Dynamics
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Daniel Bos, MD, PhD
Current Organization
Erasmus University Medical Center
Unraveling Vascular Pathways in Dementia through Integrated Computational Fluid Dynamics
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Daniel Bos, MD, PhD
Current Organization
Erasmus University Medical Center
Alzheimer's Disease Research
Linking Plaque Shapes to Amyloid Structures in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Anllely Fernandez, PhD
Current Organization
Indiana University
Linking Plaque Shapes to Amyloid Structures in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Anllely Fernandez, PhD
Current Organization
Indiana University